title: [Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update].
authors.affiliation: Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: A
authors.initials: A
authors.lastname: López-San Román
authors.forename: A
authors.initials: A
authors.lastname: Obrador
authors.forename: J
authors.initials: J
authors.lastname: Fortún
authors.forename: P
authors.initials: P
authors.lastname: Muñoz
authors.forename: M A
authors.initials: MA
authors.lastname: Gassull
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D009894:Opportunistic Infections / Q000517:prevention & control*; D014376:Tuberculosis / Q000517:prevention & control*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab